to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Arthroplasty, Replacement, Knee
Arthroplasty, Replacement, Hip
The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement.
The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty.
Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States.
Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States.
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
A New Chapter Regarding Thrombosis Risk Assessment in Total Joint Replacement Patients.